Dianthus Therapeutics (DNTH) Leases (2022 - 2025)
Historic Leases for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to $1.3 million.
- Dianthus Therapeutics' Leases rose 27102.27% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 27102.27%. This contributed to the annual value of $1.6 million for FY2024, which is 15252.03% up from last year.
- Latest data reveals that Dianthus Therapeutics reported Leases of $1.3 million as of Q3 2025, which was up 27102.27% from $1.4 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Leases ranged from a high of $25.4 million in Q1 2022 and a low of $352000.0 during Q3 2024
- Over the past 4 years, Dianthus Therapeutics' median Leases value was $1.3 million (recorded in 2025), while the average stood at $6.4 million.
- Its Leases has fluctuated over the past 5 years, first tumbled by 9708.32% in 2023, then skyrocketed by 27102.27% in 2025.
- Dianthus Therapeutics' Leases (Quarter) stood at $814000.0 in 2022, then fell by 24.45% to $615000.0 in 2023, then surged by 152.52% to $1.6 million in 2024, then dropped by 15.9% to $1.3 million in 2025.
- Its Leases stands at $1.3 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.4 million for Q1 2025.